U.S. futures slipped and Asian stocks were mixed Tuesday as investors weighed a potential setback on progress toward a coronavirus vaccine against an overnight surge in technology shares. The dollar and Treasuries advanced.
S&P 500 contracts retreated after a report that Johnson & Johnson’s Covid-19 vaccine study has been paused due to an unexplained illness in a participant. Stocks remained higher in Australia, fluctuated in Japan and dipped in South Korea and China. Earlier, the S&P 500 closed higher for a fourth day and technology leaders including Amazon.com Inc., Apple Inc. and Twitter Inc. helped the Nasdaq 100 to its biggest advance since April.
The Australian dollar slid amid reports that China has suspended purchases of Australian coal. Hong Kong scrapped its trading session as a tropical storm neared.
US After Hours ETH +12% gains on Q1 outlook update while VYGR -12% drops on regulatory update for VY-HTT01 program
Nikkei +0.13% Hang Seng Closed CSI -0.02% Shanghai -0.28% Shenzen +0.24%
Eur$ 1.1798 CNH 6.7479 CNY 6.7509 JPY 105.42 GBP 1.3050 VHF 0.9095 RUB 77.12 WTI$ 39.48 +0.13%
S&P -0.40% Nasdaq -0.34% EuroStoxx -0.09% FTSE +0.25% Dax +0.05% SMI +0.09%
Macro :
- IEA Sees Oil Demand Suffering Long-Lasting Blow From Coronavirus
- U.K. Public in Highest Risk Covid Areas Told to Limit Travel
- China’s Exports Gain, Imports Surge in September Amid Reopenings
- Europe Braces for Surge in Covid Patients to Hit Hospitals Soon
Keep an eye on :
- AIR FP : Airbus Says French Union Deal Averts Compulsory Job Cuts
- BBY LN : Balfour Beatty Seeks New Chairman as Aiken Plans to Leave: Sky
- BSLN SW : Basilea Reports Successful Completion of Phase 1B Pt of FIDES-02
- BO DC : B&O CEO Says Myth That Company Too Small to Stay Independent: JP
- DIC GY : DIC Asset Won’t Pursue Issuance of Corporate Bond
- EVT GY : Evotec to Sell 11.5m Shares to Mubadala And Novo for EU250m
- EVT GY : Abu Dhabi Wealth Fund Mubadala to Invest $235 Million in Evotec
- FAGR BB : Fagron Third Quarter Organic Revenue +8.2%
- FSKRS FH : Fiskars Reinstates FY Ebita Growth Guidance After ‘Positive’ 3Q
- GSK LN : Surface Oncology Gains on Report of Glaxo Takeover Interest
- GXI GY : Gerresheimer Confirms FY Revenue View After 3Q Revenue Miss (1)
- IVA FP : Inventiva: FDA Grants Breakthrough Designation to Lanifibranor
- MC FP : EC Review of Tiffany/LVMH Not Showing Any Issues: Dealreporter
- MOR GY : MorphoSys to Offer EU325m Convertibles With 0.625%-1.125% Coupon
- ROG SW : Roche to Launch Laboratory SARS-Cov-2 Antigen Test
- SBRE LN : Sabre Insurance Says Performance is Consistent With Expectations
- SALM NO : Salmar: Icelandic Salmon Contemplated Placement, Merkur Listing
- SAN FP : Sanofi France Head Sees Covid Vaccine Results by December
- SAN FP : Sanofi: Dupixent Significantly Cut Asthma Attacks in Children
- TIF US : EC Review of Tiffany/LVMH Not Showing Any Issues: Dealreporter
- URW NA : Unibail-Rodamco-Westfield to Sell Office Building for EU620m
- UCG IM : UniCredit May List Foreign Asset Holding Co. Separately: Sole
- VRLA FP : Verallia Names Nathalie Delbreuve as CFO, Effective Nov. 2
- VIV FP : Fortress Said to Bid $1.1 Billion for Italy’s Serie A TV Rights
- WDI GY : KPMG Was Auditor to Wirecard’s Mauritian Counterparty: FT